Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer

I. Improta, Federica Palorini, Cesare Cozzarini, T. Rancati, B. Avuzzi, P. Franco, C. Degli Esposti, E. Del Mastro, G. Girelli, C. Iotti, V. Vavassori, R. Valdagni, Claudio Fiorino

Research output: Contribution to journalArticle

Abstract

Purpose To assess bladder spatial-dose parameters predicting acute urinary toxicity after radiotherapy for prostate cancer (PCa) through a pixel-wise method for analysis of bladder dose-surface maps (DSMs). Materials & methods The final cohort of a multi-institutional study, consisting of 539 patients with PCa treated with conventionally (CONV:1.8–2 Gy/fr) or moderately hypo-fractionated radiotherapy (HYPO:2.2–2.7 Gy/fr) was considered. Urinary toxicity was evaluated through the International Prostate Symptoms Score (IPSS) administered before and after radiotherapy. IPSS increases ⩾10 and 15 points at the end of radiotherapy (ΔIPSS ⩾ 10 and ΔIPSS ⩾ 15) were chosen as endpoints. Average DSMs (corrected into 2 Gy-equivalent doses) of patients with/without toxicity were compared through a pixel-wise method. This allowed the extraction of selected spatial descriptors discriminating between patients with/without toxicity. Previously logistic models based on dose-surface histograms (DSH) were considered and replaced with DSM descriptors. Discrimination power, calibration and log-likelihood were considered to evaluate the impact of the inclusion of spatial descriptors. Results Data of 375/539 patients were available. ΔIPSS ⩾ 10 was recorded in 76/375 (20%) patients, while 30/375 (8%) experienced ΔIPSS ⩾ 15. The posterior dose at 12 mm from the bladder base (roughly corresponding to the trigone region) resulted significantly associated to toxicity in the whole/HYPO populations. The cranial extension of the 75 Gy isodose along the bladder central axis was the best DSM-based predictor in CONV patients. Multi-variable models including DSM descriptors showed better discrimination (AUC = 0.66–0.77) when compared to DSH-based models (AUC = 0.58–0.71) and higher log-likelihoods. Conclusion DSMs are correlated with the risk of acute GU toxicity. The incorporation of spatial descriptors improves discrimination and log-likelihood of multi-variable models including dosimetric and clinical parameters.
Original languageEnglish
Pages (from-to)1681 - 1689
Number of pages9
JournalPhysica Medica
Volume32
Issue number12
DOIs
Publication statusPublished - Dec 1 2016

Keywords

  • Acute urinary toxicity
  • Bladder spatial-dose descriptors
  • Dose-surface maps
  • Prostate radiotherapy

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging
  • Physics and Astronomy(all)

Fingerprint Dive into the research topics of 'Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer'. Together they form a unique fingerprint.

  • Cite this

    Improta, I., Palorini, F., Cozzarini, C., Rancati, T., Avuzzi, B., Franco, P., Degli Esposti, C., Del Mastro, E., Girelli, G., Iotti, C., Vavassori, V., Valdagni, R., & Fiorino, C. (2016). Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer. Physica Medica, 32(12), 1681 - 1689. https://doi.org/10.1016/j.ejmp.2016.08.013